Table 3.
Chemosensory loss characteristics in patients with mild, moderate, and severe COVID-19 disease.
| Patients (n = 140), n (%) | |
|---|---|
| Smell loss | 57 (41) |
| Taste loss | 53 (38) |
| Smell and taste loss | 48 (34) |
| Nasal obstruction | 16 (11) |
| Rhinorrhea | 13 (9) |
| Allergic rhinitis | 11 (8) |
| Chronic rhinosinusitis | 3 (2) |
| Smell loss severity | |
| Mild | 3 (5) |
| Moderate | 12 (21) |
| Severe | 11 (19) |
| Extremely severe (anosmia) | 31 (54) |
| Taste loss severity | |
| Mild | 3 (6) |
| Moderate | 11 (21) |
| Severe | 7 (5) |
| Extremely severe | 32 (61) |
| Smell loss recovery | 50 (88) |
| Taste loss recovery | 42 (79) |
| Hyposmia before other symptoms | 15 (26) |
| Smell loss duration (days), median (IQR) | 11.5 (13.3) |
| Taste loss duration (days), median (IQR) | 10 (8) |
n: number of patients; %: percentage; IQR: Interquartile Range.